Beta Bionics, Inc. (BBNX) Reports Q4 Loss, Tops Revenue Estimates

Beta Bionics, Inc. (BBNX) came out with a quarterly loss of $0.3 per share versus the Zacks Consensus Estimate of a loss of $0.42. This compares to a loss of $1.82 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +28.57%. A quarter ago, it was expected that this company would post a loss of $0.45 per share when it actually produced a loss of $0.33, delivering a surprise of +26.67%.Over the last four quarters, the company has su ...